K Lewandowski, K Zawilska. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Acenocoumarol/adverse effectsAcenocoumarol/therapeutic useCombined Modality TherapyFemaleHeparin/administration & dosageHeparin/therapeutic useHumansMiddle AgedNecrosisPartial Thromboplastin TimePlasmaProtein C/therapeutic useProtein C DeficiencySkin/pathologyThrombophlebitis/drug therapyWarfarin/adverse effects
Substances: See more » Protein CWarfarinHeparinAcenocoumarol
Year: 1994 PMID: 8029804
Source DB: PubMed Journal: Thromb Haemost ISSN: 0340-6245 Impact factor: 5.249